Table 1.
Clinical characteristics of patients with premature ovarian insufficiency, patients with biochemical premature ovarian insufficiency and controls.
| Variable | Control | bPOI | POI | P value |
|---|---|---|---|---|
| n | 30 | 21 | 61 | — |
| Age (year) | 31.15 ± 4.54 | 31.95 ± 4.85 | 30.93 ± 4.88 | 0.681 |
| AMH (ng/mL) | 3.83 ± 2.07 | 0.36 ± 0.33 | 0.18 ± 0.03 | <0.001 |
| AFC | 17.87 ± 8.248 | 2.94 ± 2.13 | 1.58 ± 1.91 | <0.001 |
| Basal FSH (mIU/mL) | 6.55 ± 1.41 | 15.29 ± 5.47 | 70.87 ± 33.41 | <0.001 |
| Basal LH (mIU/mL) | 5.17 ± 1.88 | 8.45 ± 1.84 | 35.82 ± 20.54 | <0.001 |
| Basal estradiol (pg/mL) | 48.31 ± 21.86 | 58.95 ± 66.87 | 41.08 ± 84.74 | 0.551 |
| Basal progesterone (ng/mL) | 0.45 ± 0.41 | 0.27 ± 0.24 | 0.37 ± 0.38 | 0.283 |
The data are presented as the mean ± standard deviation, and P < 0.05 was considered to indicate statistical significance. bPOI: biochemical premature ovarian insufficiency; POI: premature ovarian insufficiency; AMH: anti-Müllerian hormone; AFC: antral follicle count; FSH: follicle-stimulating hormone; LH: luteinizing hormone.